Population Health & ICB Programmes
High-Risk Medicines Improvement Programme
Raising monitoring standards across many practices.
What does a high-risk medicines improvement programme service do?
Raising monitoring standards across many practices. BCS supports primary care networks, gp federations, icbs across the UK from hubs in Halifax and London, covering network-wide searches, monitoring recovery, process standardisation.
Reviewed October 2026 by the BCS clinical services team.
What is this service?
High-Risk Medicines Improvement Programme from Bespoke Clinical Services: raising monitoring standards across many practices. Every arrangement is built around your organisation — truly bespoke, never off-the-shelf.
What can BCS support?
- Network-wide searches
- Monitoring recovery
- Process standardisation
- Safety dashboards
How can it be delivered?
- Commissioned programmes
- Neighbourhood teams
- Outcomes reporting
- As a defined project — no permanent contract needed
Who makes clinical decisions?
Pharmacists and technicians complete tasks within their competence and agreed scope. Medical decisions, complex cases and prescription authorisation sit with the GP. All clinicians follow your organisation's clinical governance and procedures.
How clinical governance works →How does delivery start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Ways to commission →Why choose BCS?
BCS is a truly bespoke clinical services partner. We support 50+ PCNs and 300+ GP practices with 150+ clinical pharmacists, delivered from two hubs in Halifax and London. Every clinician is backed by our management layer, structured training, clinical supervision and quality assurance, and activity is reported clearly through the BCS Impact Dashboard.
How is it funded?
Typically commissioned by an ICB, federation or provider collaborative as a defined programme or service contract.
Read our funding and ARRS guide →Common questions
What does a high-risk medicines improvement programme service do?
Raising monitoring standards across many practices. BCS supports primary care networks, gp federations, icbs across the UK from hubs in Halifax and London, covering network-wide searches, monitoring recovery, process standardisation.
Who is High-Risk Medicines Improvement Programme for?
It's designed for primary care networks, gp federations, icbs. Every arrangement is tailored to your organisation.
Can high-risk medicines improvement programme be delivered remotely?
Yes. It can be delivered remotely, on-site, or a mix of both, from our hubs in Halifax and London.
Is high-risk medicines improvement programme ARRS funded?
Typically commissioned by an ICB, federation or provider collaborative as a defined programme or service contract.
Who makes clinical decisions in high-risk medicines improvement programme?
Pharmacists and technicians complete tasks within their competence and agreed scope. Medical decisions, complex cases and prescription authorisation sit with the GP. All clinicians follow your organisation's clinical governance and procedures.
How does high-risk medicines improvement programme start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Do I need a full-time contract?
No. You can commission a defined project with an agreed scope and timeline, without a permanent staffing agreement.
Request High-Risk Medicines Improvement Programme
Tell us a little about your organisation and we'll come back within one working day with a bespoke proposal.